JPRN-UMIN000036560
Recruiting
未知
The efficacy and safety of Canagliflozin for the treatment of NAFLD/NASH patients with type2 DM - The efficacy and safety of Canagliflozin for the treatment of NAFLD/NASH patients with type2 DM
ippon Medical School Chiba Hokusoh Hospital Division of Gastroenterology0 sites30 target enrollmentMay 1, 2019
ConditionsAFLD/NASH
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- AFLD/NASH
- Sponsor
- ippon Medical School Chiba Hokusoh Hospital Division of Gastroenterology
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. pregnant woman or lactating mother 2\. poorly controlled heart failure 3\. poorly controlled hypertension or diabetes 4\. severe renal disorder 5\. decompensated liver cirrhosis 6\. other liver diseases, including autoimmune hepatitis, primary biliary cholangitis and alcoholic hepatitis, liver failure 7\. positive result for hepatitis C antibody, hepatitis B surface antigen and antibody to human immunodeficiency virus type\-1 8\. hypercarcemia 9\. hyperparathyroidism 10\. Judged by investigator not to be appropriate for inclusion in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
A clinical trial to compare the effects of Canagliflozin and Sitagliptin in Patients with Type 2 Diabetes mellitus on a background metformin therapy.Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseasesCTRI/2019/02/017435SRM College of Pharmacy40
Completed
Not Applicable
The efficacy and safety in canaglifrozin therapy for diabetes complicated by non-alcoholic fatty liver disease.onalcoholic fatty liver disease type 2 diabetes mellitusJPRN-UMIN000023044Kyoto prefetural University of Medicine20
Completed
Not Applicable
Study of the beneficial effect of Canagliflozin on nocturnal home BP in Japanese T2DM patients(SHIFT-J STUDY)Type 2 diabetes mellitus patients with hypertensionJPRN-UMIN000023487Jichi Medical University School of Medicine100
Not yet recruiting
Not Applicable
Effect of canagliflozin as an alternative drug from DPP-4 inhibitor on heart failure with diabetis melltus : the pilot study "Can canagliflozin HAve Not only hypoGlycemic but cardiac supportive Effect?"chronic heart failure with type 2 diabetis mellitusJPRN-UMIN000031563Osaka Rosai Hospital40
Active, not recruiting
Phase 1
The effect of canagliflozin 300mg on glucose levels in people without diabetes after weight loss surgery.EUCTR2019-004041-32-GBniversity of Leicester24